No Data
No Data
Cognition Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | Cognition Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $5 From $6
Chardan Capital Maintains Buy on Cognition Therapeutics, Lowers Price Target to $8
Cognition Therapeutics Analyst Ratings
Earnings Call Summary | Cognition Therapeutics(CGTX.US) Q4 2024 Earnings Conference
COGNITION THERAPEUTICS Earnings Results: $CGTX Reports Quarterly Earnings
Unlock the Full List